This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue up 36.6% and PAT up 10.8% year on year
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.9 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue from operations for the quarter ended 30 September 2026 was Rs 230.48 crore versus Rs 168.69 crore a year earlier, up 36.6%; profit after tax was Rs 19.03 crore versus Rs 17.18 crore, up 10.8%. The earnings before interest, tax, depreciation and amortisation margin fell to 11.7% from 15.9%. For the standalone half year ended 30 September 2026, operating cash flow was negative Rs 30.93 crore.
Revenue growth and higher PAT support sentiment, but margin compression and negative operating cash flow may pressure the stock.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹230.5 Cr | ₹168.7 Cr | +36.6% |
| Operating profit | ₹20.55 Cr | ₹22.05 Cr | −6.8% |
| Profit after tax | ₹19.03 Cr | ₹17.18 Cr | +10.8% |
| EBITDA margin | 11.8% | 15.9% | −4.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.